The value rally that never was

Many value stocks stayed flat on November 9 vaccine news, says factor investing expert

Covid effect on stocks

The announcement of promising results for a Covid-19 vaccine on November 9 caused stocks that had benefited during pandemic-related lockdowns to tumble. The correlation of returns for S&P 500 stocks over this day with the returns of the same stocks between February 20 and October 30 was -66%.

At face value, this looked like a rotation between factors. Long/short momentum and value equity premia made headlines in the financial press, with daily returns that represented more than 10 times their

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: